BCAB
BioAtla Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$0.17
+0.00 -1.90%
🌙 3월 13일 4:10 PM ET (한국 3/14 05:10)
$0.17
+0.00 +0.00%
| Index | - | P/E | - | EPS (ttm) | -1.15 | Insider Own | 18.94% | Shs Outstand | 0.07B | Perf Week | -1.61% |
| Market Cap | 0.01B | Forward P/E | - | EPS next Y | - | Insider Trans | - | Shs Float | 0.06B | Perf Month | -10.51% |
| Enterprise Value | 0.01B | PEG | - | EPS next Q | - | Inst Own | 12.53% | Short Float | 3.4% | Perf Quarter | -78.66% |
| Income | -0.06B | P/S | - | EPS this Y | - | Inst Trans | -0.24% | Short Ratio | 0.83 | Perf Half Y | -78.67% |
| Sales | 0.00B | P/B | - | EPS next 5Y | - | ROA | -165.61% | Short Interest | 2.05M | Perf YTD | -70.92% |
| Book/sh | -0.53 | P/C | 1.47 | EPS past 3/5Y | 19.57% -10.97% | ROE | -813.88% | 52W High | -88.45% ($1.43) | Perf Year | -49.07% |
| Cash/sh | 0.11 | P/FCF | - | Sales past 3/5Y | 253.03% 16.17% | ROIC | - | 52W Low | 27% ($0.13) | Perf 3Y | -93.29% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 32.37% | Gross Margin | - | Volatility(W/M) | 11% 15.99% | Perf 5Y | -99.75% |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | -100% | Oper. Margin | - | ATR (14) | 0.03 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 0.54 | EPS Q/Q | -22.65% | Profit Margin | - | RSI (14) | 38.73 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 0.54 | Sales Q/Q | -100% | SMA20 | -7.91% ($0.18) | Beta | 1.16 | Target Price | $4 |
| Payout | - | Debt/Eq | - | Earnings | 11000000 | SMA50 | -35.93% ($0.27) | Rel Volume | 0.35 | Prev Close | $0.17 |
| Employees | 76 | LT Debt/Eq | - | EPS/Sales Surpr. | 9% - | SMA200 | -67.61% ($0.52) | Avg Volume(3M) | 2.47M | Price | $0.17 |
| IPO | 2020/12/16 | Option/Short | Yes/Yes | Trades | 1086 | Volume | 862,422 | Change | -1.9% |
뉴스 로딩 중...